虹美菱B(200521):2022年半年度财务报告(英文版)
|
时间:2022年08月17日 20:12:31 中财网 |
|
原标题:虹美菱B:2022年半年度财务报告(英文版)
CHANGHONG MEILING CO., LTD.
SEMI-ANNUAL FINANCIAL REPORT 2022
August 2022
CHANGHONG MEILING CO., LTD
SEMI-ANNUAL FINANCIAL REPORT 2022 (Unaudited)
I. Audit report
Whether the semi annual report is audited
□ Yes √ No
The company's semi annual financial report has not been audited II. Financial Statement
Statement in Financial Notes are carried in RMB/CNY
1. Consolidated Balance Sheet
Prepared by CHANGHONG MEILING CO., LTD.
June 30, 2022
In RMB
Item | June 30, 2022 | January 1, 2022 | Current assets: | | | Monetary funds | 6,183,005,095.11 | 5,938,823,396.21 | Settlement provisions | | | Capital lent | | | Trading financial assets | 208,184,795.23 | 17,997,086.19 | Derivative financial assets | | | Note receivable | 439,419.03 | 2,216,752.22 | Account receivable | 2,270,853,232.12 | 1,440,874,691.28 | Receivable financing | 1,380,100,294.09 | 1,808,109,301.56 | Accounts paid in advance | 28,724,589.92 | 29,766,797.34 | Insurance receivable | | | Reinsurance receivables | | | Contract reserve of reinsurance receivable | | | Other account receivable | 101,572,345.96 | 111,652,635.86 | Including: Interest receivable | | | Dividend receivable | | | Buying back the sale of financial assets | | | Inventories | 1,607,718,382.71 | 1,356,357,419.80 | Contractual assets | 2,313,522.40 | | Assets held for sale | | | Non-current asset due within one year | | | Other current assets | 93,325,665.28 | 124,240,934.45 | Total current assets | 11,876,237,341.85 | 10,830,039,014.91 | Non-current assets: | | | Loans and payments on behalf | | | Debt investment | 291,305,319.44 | | Other debt investment | | | Long-term account receivable | | | Long-term equity investment | 88,915,648.08 | 86,631,660.53 | Investment in other equity instrument | | | Other non-current financial assets | 576,200,641.50 | 581,980,440.70 | Investment real estate | 52,191,185.68 | 53,149,934.45 | Fixed assets | 2,266,504,611.74 | 2,303,122,699.92 | Construction in progress | 103,923,104.08 | 98,469,862.45 | Productive biological asset | | | Oil and gas asset | | | Right-of-use assets | 40,286,720.53 | 45,367,918.31 | Intangible assets | 910,035,679.68 | 953,403,100.33 | Expense on Research and Development | 137,625,624.69 | 87,728,990.86 | Goodwill | | | Long-term expenses to be apportioned | 362,898.05 | | Deferred income tax asset | 173,152,065.58 | 147,488,353.28 | Other non-current asset | 999,030.66 | 3,087,780.59 | Total non-current asset | 4,641,502,529.71 | 4,360,430,741.42 | Total assets | 16,517,739,871.56 | 15,190,469,756.33 | Current liabilities: | | | Short-term loans | 1,087,291,446.15 | 622,874,652.77 | Loan from central bank | | | Capital borrowed | | | Trading financial liability | 38,929,244.41 | 12,304,272.41 | Derivative financial liability | | | Note payable | 4,502,920,235.46 | 4,839,837,317.78 | Account payable | 3,832,859,258.27 | 2,299,103,796.88 | Accounts received in advance | | | Contractual liability | 351,317,980.38 | 515,004,115.23 | Selling financial asset of repurchase | | | Absorbing deposit and interbank deposit | | | Security trading of agency | | | Security sales of agency | | | Wage payable | 222,392,707.91 | 247,044,421.56 | Taxes payable | 149,559,048.33 | 141,874,861.88 | Other account payable | 903,778,941.60 | 751,452,768.00 | Including: Interest payable | | | Dividend payable | 19,793,050.41 | 4,753,764.56 | Commission charge and commission payable | | | Reinsurance payable | | | Liability held for sale | | | Non-current liabilities due within one year | 30,243,710.95 | 332,718,478.25 | Other current liabilities | 22,377,103.22 | 24,373,759.16 | Total current liabilities | 11,141,669,676.68 | 9,786,588,443.92 | Non-current liabilities: | | | Insurance contract reserve | | | Long-term loans | 158,000,000.00 | 168,000,000.00 | Bonds payable | | | Including: Preferred stock | | | Perpetual capital securities | | | Lease liability | 30,061,422.30 | 33,225,912.15 | Long-term account payable | 1,241,464.86 | 1,337,643.24 | Long-term wages payable | 8,710,896.43 | 9,828,300.06 | Accrual liability | 11,912,507.94 | 11,363,601.63 | Deferred income | 163,159,009.25 | 175,664,038.83 | Deferred income tax liabilities | 8,889,141.90 | 9,670,435.45 | Other non-current liabilities | | | Total non-current liabilities | 381,974,442.68 | 409,089,931.36 | Total liabilities | 11,523,644,119.36 | 10,195,678,375.28 | Owner’s equity: | | | Share capital | 1,029,923,715.00 | 1,044,597,881.00 | Other equity instrument | | | Including: Preferred stock | | | Perpetual capital securities | | | Capital public reserve | 2,670,335,732.53 | 2,682,829,400.26 | Less: Inventory shares | | 26,430,571.38 | Other comprehensive income | -20,842,082.96 | -20,903,270.57 | Reasonable reserve | | | Surplus public reserve | 423,111,236.90 | 423,111,236.90 | Provision of general risk | | | Retained profit | 743,008,737.50 | 734,129,724.00 | Total owner’ s equity attributable to parent company | 4,845,537,338.97 | 4,837,334,400.21 | Minority interests | 148,558,413.23 | 157,456,980.84 | Total owner’ s equity | 4,994,095,752.20 | 4,994,791,381.05 | Total liabilities and owner’ s equity | 16,517,739,871.56 | 15,190,469,756.33 |
Legal Representative: Wu Dinggang
Person in charge of accounting works: Pang Haitao
Person in charge of accounting institute: Yang Jun
2. Balance Sheet of Parent Company
In RMB
Item | June 30, 2022 | January 1, 2022 | Current assets: | | | Monetary funds | 3,266,271,511.03 | 3,423,276,377.52 | Trading financial assets | 17,312,173.84 | 7,200,222.04 | Derivative financial assets | | | Note receivable | | 330,000.00 | Account receivable | 1,735,966,866.26 | 1,582,651,896.25 | Receivable financing | 966,511,549.26 | 1,484,609,403.08 | Accounts paid in advance | 44,903,647.89 | 48,212,105.70 | Other account receivable | 38,833,840.97 | 40,708,614.68 | Including: Interest receivable | | | Dividend receivable | | | Inventories | 364,105,226.52 | 351,523,851.67 | Contractual assets | 46,970.75 | | Assets held for sale | | | Non-current assets maturing within one year | | | Other current assets | | 28,957,697.04 | Total current assets | 6,433,951,786.52 | 6,967,470,167.98 | Non-current assets: | | | Debt investment | 291,305,319.44 | | Other debt investment | | | Long-term receivables | | | Long-term equity investments | 1,882,997,437.73 | 1,882,557,241.66 | Investment in other equity instrument | | | Other non-current financial assets | 576,200,641.50 | 581,980,440.70 | Investment real estate | 3,648,311.42 | 3,752,737.75 | Fixed assets | 1,171,285,355.31 | 1,209,058,847.63 | Construction in progress | 78,324,001.26 | 50,287,155.16 | Productive biological assets | | | Oil and natural gas assets | | | Right-of-use assets | 17,686,308.69 | 18,632,705.13 | Intangible assets | 454,904,294.76 | 477,739,048.08 | Research and development costs | 86,047,186.86 | 44,387,584.10 | Goodwill | | | Long-term deferred expenses | | | Deferred income tax assets | 141,353,431.80 | 125,174,589.66 | Other non-current assets | 299,020.00 | 638,649.57 | Total non-current assets | 4,704,051,308.77 | 4,394,208,999.44 | Total assets | 11,138,003,095.29 | 11,361,679,167.42 | Current liabilities: | | | Short-term borrowings | 1,052,171,543.37 | 612,863,194.44 | Trading financial liability | 14,509,627.08 | 5,766,743.33 | Derivative financial liability | | | Notes payable | 1,877,201,607.34 | 2,409,104,654.05 | Account payable | 1,485,308,607.13 | 1,356,405,016.24 | Accounts received in advance | | | Contractual liability | 152,733,929.04 | 238,437,143.59 | Wage payable | 6,018,076.56 | 42,679,625.89 | Taxes payable | 22,888,141.57 | 20,596,813.11 | Other accounts payable | 1,078,306,911.70 | 909,832,533.11 | Including: Interest payable | | | Dividend payable | 19,193,050.41 | 4,153,764.56 | Liability held for sale | | | Non-current liabilities due within one year | 22,098,167.21 | 322,202,348.59 | Other current liabilities | 6,982,077.34 | 6,703,328.85 | Total current liabilities | 5,718,218,688.34 | 5,924,591,401.20 | Non-current liabilities: | | | Long-term loans | 158,000,000.00 | 168,000,000.00 | Bonds payable | | | Including: Preferred stock | | | Perpetual capital securities | | | Lease liability | 16,523,542.32 | 17,114,473.86 | Long-term account payable | | | Long term employee compensation payable | 7,562,998.28 | 8,760,963.52 | Accrued liabilities | 6,135,182.74 | 7,539,547.19 | Deferred income | 77,695,276.53 | 82,658,197.54 | Deferred income tax liabilities | 5,700,451.84 | 6,131,087.92 | Other non-current liabilities | | | Total non-current liabilities | 271,617,451.71 | 290,204,270.03 | Total liabilities | 5,989,836,140.05 | 6,214,795,671.23 | Owners’ equity: | | | Share capital | 1,029,923,715.00 | 1,044,597,881.00 | Other equity instrument | | | Including: Preferred stock | | | Perpetual capital securities | | | Capital public reserve | 2,740,508,510.57 | 2,753,002,178.30 | Less: Inventory shares | | 26,430,571.38 | Other comprehensive income | | | Special reserve | | | Surplus reserve | 422,893,071.22 | 422,893,071.22 | Retained profit | 954,841,658.45 | 952,820,937.05 | Total owner’s equity | 5,148,166,955.24 | 5,146,883,496.19 | Total liabilities and owner’s equity | 11,138,003,095.29 | 11,361,679,167.42 |
3. Consolidated Profit Statement
In RMB
Item | Semi-annual of 2022 | Semi-annual of 2021 | I. Total operating income | 10,224,503,551.19 | 9,602,759,345.29 | Including: Operating income | 10,224,503,551.19 | 9,602,759,345.29 | Interest income | | | Insurance gained | | | Commission charge and commission income | | | II. Total operating cost | 10,156,306,873.88 | 9,556,489,547.17 | Including: Operating cost | 9,061,080,531.06 | 8,177,231,196.17 | Interest expense | | | Commission charge and commission expense | | | Cash surrender value | | | Net amount of expense of compensation | | | Net amount of withdrawal of insurance contract reserve | | | Bonus expense of guarantee slip | | | Reinsurance expense | | | Tax and extras | 79,701,444.29 | 61,077,730.97 | Sales expense | 666,066,309.98 | 984,805,928.94 | Administrative expense | 164,132,141.97 | 152,957,426.98 | R&D expense | 248,112,774.54 | 186,113,254.21 | Financial expense | -62,786,327.96 | -5,695,990.10 | Including: Interest expenses | 16,913,382.96 | 37,292,383.25 | Interest income | 66,581,155.37 | 62,433,816.96 | Add: Other income | 48,325,391.81 | 57,250,100.93 | Investment income (Loss is listed with “-”) | 13,816,261.75 | 52,533,705.90 | Including: Investment income on affiliated company and joint
venture | 8,971,315.55 | -16,047,810.77 | The termination of income recognition for financial assets
measured by amortized cost | -10,198,142.54 | | Exchange income (Loss is listed with “-”) | | | Net exposure hedging income (Loss is listed with “-”) | | | Income from change of fair value (Loss is listed with “-”) | 3,562,737.04 | -9,731,654.29 | Loss of credit impairment (Loss is listed with “-”) | -50,466,619.13 | -15,121,003.89 | Losses of devaluation of asset (Loss is listed with “-”) | -29,791,822.84 | -43,310,366.42 | Income from assets disposal (Loss is listed with “-”) | 8,358,775.10 | -208,978.90 | III. Operating profit (Loss is listed with “-”) | 62,001,401.04 | 87,681,601.45 | Add: Non-operating income | 2,910,887.79 | 5,862,320.71 | Less: Non-operating expense | 2,332,960.83 | 760,592.62 | IV. Total profit (Loss is listed with “-”) | 62,579,328.00 | 92,783,329.54 | Less: Income tax expense | -10,115,573.46 | 37,086,971.38 | V. Net profit (Net loss is listed with “-”) | 72,694,901.46 | 55,696,358.16 | (i) Classify by business continuity | | | 1.continuous operating net profit (net loss listed with ‘-”) | 72,694,901.46 | 55,696,358.16 | 2.termination of net profit (net loss listed with ‘-”) | | | (ii) Classify by ownership | | | 1.Net profit attributable to owner’s of parent company | 60,375,199.25 | 37,157,511.54 | 2.Minority shareholders’ gains and losses | 12,319,702.21 | 18,538,846.62 | VI. Net after-tax of other comprehensive income | 161,477.79 | -1,257,750.59 | Net after-tax of other comprehensive income attributable to owners of
parent company | 61,187.61 | -1,271,363.35 | (I) Other comprehensive income items which will not be reclassified
subsequently to profit of loss | | | 1.Changes of the defined benefit plans that re-measured | | | 2.Other comprehensive income under equity method that
cannot be transfer to gain/loss | | | 3.Change of fair value of investment in other equity instrument | | | 4.Fair value change of enterprise's credit risk | | | 5. Other | | | (ii) Other comprehensive income items which will be reclassified
subsequently to profit or loss | 61,187.61 | -1,271,363.35 | 1.Other comprehensive income under equity method that can
transfer to gain/loss | | -177,046.32 | 2.Change of fair value of other debt investment | | | 3.Amount of financial assets re-classify to other
comprehensive income | | | 4.Credit impairment provision for other debt investment | | | 5.Cash flow hedging reserve | | | 6.Translation differences arising on translation of foreign
currency financial statements | 61,187.61 | -1,094,317.03 | 7.Other | | | Net after-tax of other comprehensive income attributable to minority
shareholders | 100,290.18 | 13,612.76 | VII. Total comprehensive income | 72,856,379.25 | 54,438,607.57 | Total comprehensive income attributable to owners of parent
Company | 60,436,386.86 | 35,886,148.19 | Total comprehensive income attributable to minority shareholders | 12,419,992.39 | 18,552,459.38 | VIII. Earnings per share: | | | (i) Basic earnings per share | 0.0582 | 0.0356 | (ii) Diluted earnings per share | 0.0582 | 0.0356 |
As for the enterprise combined under the same control, net profit of 0 yuan achieved by the merged party before
combination while 0 yuan achieved last period
Legal Representative: Wu Dinggang
Person in charge of accounting works: Pang Haitao
Person in charge of accounting institute: Yang Jun
4. Profit Statement of Parent Company
In RMB
Item | Semi-annual of 2022 | Semi-annual of 2021 | I. Operating income | 3,276,506,161.47 | 3,975,751,904.29 | Less: Operating cost | 3,060,604,345.52 | 3,701,614,201.55 | Taxes and surcharge | 27,794,762.55 | 21,839,365.11 | Sales expenses | 80,728,268.23 | 99,271,533.62 | Administration expenses | 53,782,990.89 | 56,254,420.78 | R&D expenses | 108,366,509.30 | 72,054,454.73 | Financial expenses | -22,635,899.49 | -4,429,587.19 | Including: Interest expenses | 16,599,488.01 | 29,845,405.90 | Interest income | 36,123,851.00 | 39,962,405.83 | Add: Other income | 21,184,281.25 | 36,911,268.50 | Investment income (Loss is listed with “-”) | 47,530,171.27 | 37,411,973.74 | Including: Investment income on affiliated Company and joint
venture | 5,509,596.07 | -15,045,065.49 | The termination of income recognition for financial assets | -1,663,033.71 | | measured by amortized cost (Loss is listed with “-”) | | | Net exposure hedging income (Loss is listed with “-”) | | | Changing income of fair value (Loss is listed with “-”) | 1,369,068.05 | -21,631,996.66 | Loss of credit impairment (Loss is listed with “-”) | -7,829,056.61 | -528,447.83 | Losses of devaluation of asset (Loss is listed with “-”) | -1,325,668.27 | -3,955,719.18 | Income on disposal of assets (Loss is listed with “-”) | 8,344,824.89 | -82,639.64 | II. Operating profit (Loss is listed with “-”) | 37,138,805.05 | 77,271,954.62 | Add: Non-operating income | 857,194.10 | 2,299,511.52 | Less: Non-operating expense | 1,088,570.22 | 288,232.95 | III. Total Profit (Loss is listed with “-”) | 36,907,428.93 | 79,283,233.19 | Less: Income tax | -16,609,478.22 | 15,578,001.89 | IV. Net profit (Net loss is listed with “-”) | 53,516,907.15 | 63,705,231.30 | (i) continuous operating net profit (net loss listed with ‘-”) | 53,516,907.15 | 63,705,231.30 | (ii) termination of net profit (net loss listed with ‘-”) | | | V. Net after-tax of other comprehensive income | | | (i) Other comprehensive income items which will not be reclassified
subsequently to profit of loss | | | 1.Changes of the defined benefit plans that re-measured | | | 2.Other comprehensive income under equity method that cannot
be transfer to gain/loss | | | 3.Change of fair value of investment in other equity instrument | | | 4.Fair value change of enterprise's credit risk | | | 5. Other | | | (ii) Other comprehensive income items which will be reclassified
subsequently to profit or loss | | | 1.Other comprehensive income under equity method that can
transfer to gain/loss | | | 2.Change of fair value of other debt investment | | | 3.Amount of financial assets re-classify to other comprehensive
income | | | 4.Credit impairment provision for other debt investment | | | 5.Cash flow hedging reserve | | | 6.Translation differences arising on translation of foreign
currency financial statements | | | 7.Other | | | VI. Total comprehensive income | 53,516,907.15 | 63,705,231.30 | VII. Earnings per share: | | | (i) Basic earnings per share | 0.0516 | 0.0610 | (ii) Diluted earnings per share | 0.0516 | 0.0610 |
5. Consolidated Cash Flow Statement
In RMB
Item | Semi-annual of 2022 | Semi-annual of 2021 | I. Cash flows arising from operating activities: | | | Cash received from selling commodities and providing labor
services | 10,312,619,575.60 | 8,512,320,086.90 | Net increase of customer deposit and interbank deposit | | | Net increase of loan from central bank | | | Net increase of capital borrowed from other financial institution | | | Cash received from original insurance contract fee | | | Net cash received from reinsurance business | | | Net increase of insured savings and investment | | | Cash received from interest, commission charge and commission | | | Net increase of capital borrowed | | | Net increase of returned business capital | | | Net cash received by agents in sale and purchase of securities | | | Write-back of tax received | 379,915,276.10 | 316,502,790.54 | Other cash received concerning operating activities | 72,807,336.47 | 79,642,427.61 | Subtotal of cash inflow arising from operating activities | 10,765,342,188.17 | 8,908,465,305.05 | Cash paid for purchasing commodities and receiving labor
service | 8,685,143,427.78 | 7,728,511,418.75 | Net increase of customer loans and advances | | | Net increase of deposits in central bank and interbank | | | Cash paid for original insurance contract compensation | | | Net increase of capital lent | | | Cash paid for interest, commission charge and commission | | | Cash paid for bonus of guarantee slip | | | Cash paid to/for staff and workers | 859,700,605.67 | 860,117,506.67 | Taxes paid | 254,144,466.19 | 145,836,080.82 | Other cash paid concerning operating activities | 391,300,471.18 | 762,496,415.63 | Subtotal of cash outflow arising from operating activities | 10,190,288,970.82 | 9,496,961,421.87 | Net cash flows arising from operating activities | 575,053,217.35 | -588,496,116.82 | II. Cash flows arising from investing activities: | | | Cash received from recovering investment | 221,539,824.00 | 700,000,000.00 | Cash received from investment income | 17,907,264.72 | 6,856,855.12 | Net cash received from disposal of fixed, intangible and other
long-term assets | 15,074,662.60 | 1,095,433.16 | Net cash received from disposal of subsidiaries and other units | | | Other cash received concerning investing activities | 65,647,218.13 | 138,387,471.00 | Subtotal of cash inflow from investing activities | 320,168,969.45 | 846,339,759.28 | Cash paid for purchasing fixed, intangible and other long-term
assets | 132,916,669.27 | 125,772,890.37 | Cash paid for investment | 1,024,040,000.00 | 1,420,000,000.00 | Net increase of mortgaged loans | | | Net cash received from subsidiaries and other units obtained | | | Other cash paid concerning investing activities | 7,635,033.86 | 47,506.93 | Subtotal of cash outflow from investing activities | 1,164,591,703.13 | 1,545,820,397.30 | Net cash flows arising from investing activities | -844,422,733.68 | -699,480,638.02 | III. Cash flows arising from financing activities: | | | Cash received from absorbing investment | | 15,000,000.00 | Including: Cash received from absorbing minority shareholders’
investment by subsidiaries | | 15,000,000.00 | Cash received from loans | 647,040,918.37 | 934,661,487.16 | Other cash received concerning financing activities | 84,181.37 | 4,675,857.30 | Subtotal of cash inflow from financing activities | 647,125,099.74 | 954,337,344.46 | Cash paid for settling debts | 490,000,000.00 | 1,232,876,410.00 | Cash paid for dividend and profit distributing or interest paying | 76,995,651.40 | 66,120,511.52 | Including: Dividend and profit of minority shareholder paid by
subsidiaries | 21,318,560.00 | 1,598,892.00 | Other cash paid concerning financing activities | 432,350,094.27 | 11,341,697.18 | Subtotal of cash outflow from financing activities | 999,345,745.67 | 1,310,338,618.70 | Net cash flows arising from financing activities | -352,220,645.93 | -356,001,274.24 | IV. Influence on cash and cash equivalents due to fluctuation in
exchange rate | 19,041,476.23 | -14,000,285.27 | V. Net increase of cash and cash equivalents | -602,548,686.03 | -1,657,978,314.35 | Add: Balance of cash and cash equivalents at the period -begin | 5,840,194,931.57 | 6,425,529,815.10 | VI. Balance of cash and cash equivalents at the period -end | 5,237,646,245.54 | 4,767,551,500.75 |
6. Cash Flow Statement of Parent Company (未完)
|
|